The Branded-Ingredient Business Model
How 'clinically studied' ingredients reach your supplement
Evidence grade 3 of 5, Mixed. Read how the Atlas grades evidence.
The written rationale for this grade is still being prepared.
- FDA
- Not applicable (industry analysis)
Reference only. Not medical advice.
What can go wrong
Three structural issues: (1) supplier-funded trials carry conflict of interest; (2) consumer products often under-dose or use a different form than the studied extract; (3) the finished product almost never has its own trial, yet 'clinically studied' implies it does.
This is something to take to a clinician. The Atlas can tell you what is known about the branded-ingredient business model in general. It cannot tell you what is happening in your body, and the difference matters most for exactly the symptoms that bring people to this page.
Behind nearly every testosterone supplement is an ingredient-supplier business model. Companies like Ixoreal (KSM-66), Natreon (Sensoril, PrimaVie), Sabinsa (ForsLean, BioPerine), Gencor (Testofen, Tesnor), HP Ingredients (LJ100), and Biotropics (Physta) develop a standardized branded extract, fund the clinical trials on it, secure trademarks/patents, and license it to consumer brands, who then market 'clinically studied ingredients.' The critical consumer-protection point: the trial was on the ingredient (often at a specific dose, supplier-funded), not on the finished product, which is almost never tested as a complete formula.
'Clinically studied ingredient' is not the same as 'clinically studied product.'
What people take it for
These are the reasons people give for taking it. They are not effects it has been shown to have.
What people get wrong
Often said'Contains clinically studied ingredients' means the product is clinically proven
ActuallyIt means a supplier funded a study on the raw ingredient, frequently at a higher dose or different form than the product uses. The finished formula is essentially never tested.
Who profits, and who pushes back
Nobody is named here yet, because we have not done that work on this entry. Read that as unfinished. Somebody almost certainly sells this, and somebody almost certainly disputes it. Assume both until we have checked.
At a glance
- Suppliers
- Ixoreal, Natreon, Sabinsa, Gencor, HP Ingredients
- Model
- Supplier funds ingredient trials, licenses to brands
- The gap
- Ingredient studied != product tested
What this entry does not yet cover
What follows is unfinished work on our side, not a finding about The Branded-Ingredient Business Model. A short entry is not a safe entry.
- Timeline. We have not built the dated record of research and regulatory events.
- Cost and market. We have not documented what it sells for or who sells it.
- Supply chain. We have not mapped where it is made.
- Who uses it. We have not documented the user groups.
- What could change. No forward-looking summary yet.
- How it compares. We have not set it against the alternatives.
- Children and teenagers. We have not checked what is known about younger people.
Sources
No sources recorded for this entry yet. Nothing on this page can be checked against a citation until that changes, so treat it as a summary awaiting its evidence.